Across TCGA patient cohorts, C6orf163 mutation is significantly associated with the immune_cell of many other genes, with 4 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible C6orf163-associated genes across cancer lineages are cDC, DC, and CD8+ T-cells. Each is linked with C6orf163 in more than 1 cancer types. Because this analysis shows association rather than direction, both C6orf163-to-partner and partner-to-C6orf163 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (C6orf163→partner) and Y-score (partner→C6orf163) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
UCEC	cDC →	+0.140	+2.815	.001	.036	3	2
UCEC	DC →	+0.029	+2.326	.010	.036	3	2
UCEC	CD8+ T-cells →	+0.015	+2.622	.022	.022	3	1
UCEC	CD8+ Tcm →	+0.030	+2.713	.004	.018	3	1

Each partner links to its Q-omics profile. Showing the 4 strongest of 4 associations by consensus.

Exploration

C6orf163 survival (RNA) · tumor vs normal (RNA) · all C6orf163 data types